Drug Pipeline

STP938 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
3
Recruiting
1
Top Sponsors
Active Studies by Phase
Phase 1/2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT05463263 A Phase 1/2 Study of STP938 for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell… Lymphoma, B-Cell Recruiting
Phase 1
NCT06786234 A Phase 1 Study to Assess STP938 as a Monotherapy in Adults With High Risk Essential… Essential Thrombocythaemia Recruiting
NCT06297525 Study of STP938 in Advanced Solid Tumours Solid Tumor Recruiting
Sponsors Running STP938 Trials
Step Pharma, SAS (3)
Get alerts when STP938 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free